Enliven Therapeutics, Inc. — S-8 Filings
9 S-8 filings on record
This page lists all S-8 filings submitted to the SEC by Enliven Therapeutics, Inc. (ELVN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Enliven Therapeutics, Inc. has filed 9 S-8 documents with the SEC since 2016. To view all SEC filings by Enliven Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001193125-26-088785 | Mar 3, 2026 | — |
| S-8 | S-8 | 0001193125-25-320872 | Dec 16, 2025 | — |
| S-8 | S-8 | 0001193125-25-054024 | Mar 13, 2025 | — |
| S-8 | S-8 | 0001193125-24-163646 | Jun 20, 2024 | — |
| S-8 | S-8 | 0001193125-24-068024 | Mar 14, 2024 | — |
| S-8 | S-8 | 0001193125-23-056480 | Mar 1, 2023 | — |
| S-8 | S-8 | 0001564590-22-010223 | Mar 15, 2022 | — |
| S-8 | S-8 | 0001564590-21-041915 | Aug 6, 2021 | — |
| S-8 | S-8 | 0001193125-20-071587 | Mar 12, 2020 | — |